Janiczek Wealth Management, LLC Genmab A/S Transaction History

Janiczek Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$26.43 - $32.77 $9,779 - $12,124	370 New	370 $11,000
Q4 2022 Jan 20, 2023	BUY	$33.8 - $47.06 $3,041 - $4,235	90 New	90 $0
Q1 2022 May 05, 2022	SELL	$30.95 - $39.68 $619 - $793	-20 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$32.88 - $44.57 $657 - $891	20 New	20 $1,000
Q1 2021 Apr 28, 2021	SELL	$30.92 - $44.4 $2,782 - $3,996	-90 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$33.66 - $40.76 $3,029 - $3,668	90 New	90 $4,000
Q3 2020 Oct 19, 2020	SELL	$33.07 - $38.68 $1,554 - $1,817	-47 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$20.05 - $33.89 $942 - $1,592	47 New	47 $2,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.